National Stock Number
6505-01-255-0851
National Stock Number (NSN) 6505-01-255-0851, or NIIN 012550851, (iothalamate meglumine injection) was assigned May 15, 1987 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.
There are 6 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 4 suppliers. Today, 3 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 2 suppliers are deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over a year. There have been 46 contracts issued for this part number, with 38 awards given. There is moderate competition for this NSN. The US Government has awarded contracts to 8 different suppliers. The last contract numbers awarded were: SPE2DP23P0080, SPE2DP23P0080, SPE2DP23P0080, SPE2DP23P0080, SPE2DP23P0079. The total value of the awarded contracts has been US$ 88,991.23.
There has been a moderate amount of demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Apr 21, 2016, this NSN's acquisition method was noted as: Suitable for Competitive Acquisition. (Potential sources shall include dealers/distributors.) This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.
This NSN is assigned to Item Name Code (INC) 28736. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505012550851 does not contain precious metals.
This NSN is associated to Schedule B 3006300000: opacifying preparations for x-ray examinations; diagnostic reageants designed to be administered to the patient. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325412: pharmaceutical preparation manufacturing.
This information was last updated on Aug 01, 2025.